Inhibitors
Antibodies

Primary Antibodies

Invivo Functional Antibodies

Biosimilar Antibodies
Compound Libraries
New Products
Contact Us

BI-2865 Combination Database

Validated BI-2865 Combination Schemes—Peer-Reviewed Data Compiled from Primary Literature.

🎯 check BI-2865 product page

BI-2865 Combination Database

Please select the combination compounds (Multiple selections allowed)

Please select a combination compound first

Jump to:

BI-2865 Mechanism of Action: KRAS Inhibition in Cancer Cell Research
Selectivity & Specificity
BI-2865 Working Concentration | Cell Culture | Treatment
BI-2865 Solubility in DMSO
BI-2865 Storage & Stability
BI-2865 Molecular Weight | Chemical Structure | Stock Solution
BI-2865 IC50 for Cell-based and Cell-free Assays
BI-2865 Sigma (SML4151)? Try a better option.
BI-2865 MCE (HY-153724)? Try a better option.
BI-2865 Abmole (M40499)? Try a better option.
BI-2865 TargetMol (T72061)? Try a better option.
BI-2865 BPS Bioscience (82711-3)? Try a better option.
BI-2865 SDS｜MSDS
BI-2865 in Pan-KRAS Targeted Therapy for Solid Tumors
BI-2865 in Multidrug Resistance Reversal
BI-2865 in Combination Therapy and Acquired Resistance